36th Annual CFS®

Credit Designation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Physicians’ Education Resource®, LLC and Pharmacy Times Continuing Education. Physicians’ Education Resource®, LLC is accredited by the ACCME to provide continuing medical education for physicians.

This activity is approved for AMA PRA Category 1 Credit™.

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is eligible for ACPE credit; see final CPE activity announcement for specific details.

36th Annual CFS®

36th Annual CFS®

Wednesday, November 7, 2018 – Friday, November 9, 2018
New York Marriott Marquis
1535 Broadway

New York, NY 10036
(800) 843-4898


Breathtaking changes continue to occur in the management of solid and hematologic malignancies. Just this past year, practice-changing diagnostic, therapeutic, and supportive care strategies have entered clinical practice, and many more are poised to soon enter the field. Evidence supports improved outcomes in multiple lines of care with the application of novel testing approaches, systemic therapies, molecularly targeted therapies, immunotherapies, and multimodal strategies. Critical knowledge and competence gaps among practitioners must be addressed so these new approaches to care can be effectively and safely integrated into contemporary practices. Each year, the CFS®, brings together more than 2,000 oncologists, hematologists, radiation oncologists, immunologists, pharmacists, oncology nurses, nurse practitioners, physician assistants, and case managers, with the aim of promoting the delivery of state-of-the-art cancer care for the most challenging clinical scenarios. At the 36th Annual CFS®, our internationally renowned faculty will provide expert insights on the latest developments in cancer therapeutics. This exciting 3-day program will offer oncology practitioners an unparalleled opportunity to learn how innovative approaches fit into evolving treatment paradigms to optimize care and outcomes for their patients with cancer.

Target Audience:

This educational activity is directed toward oncologists, hematologists, nurses, nurse practitioners, and pharmacists interested in the treatment/management of patients with cancer. Radiotherapists, immunologists, fellows, physician assistants, researchers, case managers, and other healthcare professionals interested in the treatment of cancer are also invited to attend.

Learning Objectives:

Upon completion of this activity, participants should be better prepared to:

  1. Determine the most appropriate testing strategies to stratify risk and inform clinical decision-making in the management of cancer
  2. Describe important clinical trial results that inform treatment practices and are altering care paradigms for patients with hematologic malignancies and solid tumors
  3. Identify immunotherapeutic, chemotherapeutic, and targeted approaches demonstrated by recent evidence to optimize clinical outcomes
  4. Delineate methods multidisciplinary teams can proactively apply to prevent and mitigate the impact of treatment-related toxicities findings in the context of evolving treatment pathways to improve care for patients with cancer
  5. Assess practice-changing evidence and apply these findings in the context of evolving treatment paradigms to optimize the care of patients with cancer

Program Co-Chairs

Adam M. Brufsky, MD, PhD
Professor of Medicine
Associate Chief, Division of Hematology/ Oncology
Co-Director, Comprehensive Breast Cancer Center Associate
Director, Clinical Investigation
University of Pittsburgh
Pittsburgh, PA

Benjamin Levy, MD
Clinical Director of Medical Oncology
Johns Hopkins Sidney Kimmel Cancer Center
Sibley Memorial Hospital
Washington, DC

William Oh, MD
Chief, Division of Hematology and Medical Oncology
Professor of Medicine and Urology
Ezra M. Greenspan, MD Professor in Clinical Cancer Therapeutics
Icahn School of Medicine at Mount Sinai
Associate Director of Clinical Research
The Tisch Cancer Institute
New York, NY

Free Registration for Pharmicists registering for CFS™. Directions in Oncology Pharmacy.

Calendar of Events
Filter By